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The integration of chromatin modifiers into specific regulatory networks is not fully understood. In this issue
of Immunity, Austenaa et al. (2012) demonstrate a specific role for the histone methyltransferase MLL4
(Wbp7) in controlling the expression of critical molecules in the Toll-like receptor pathway.The epigenetic code is composed of
chemical modifications on histone pro-
teins or DNA, which affect genome out-
put in a sequence-independent manner.
These modifications play a critical role in
gene regulation and are involved in both
normal physiology and disease. Epige-
nomic modifications can overlay on the
DNA sequence long-term ‘‘memory’’ of a
particular event or stimuli that the cell
has encountered. For example, as cells
differentiate they acquire various histone
modifications in specific genomic loci,
which restrict them to a particular cell
lineage. Histone modifying complexes—
readers, writers, and erasers—are com-
plexes that bind, add, or remove partic-
ular modifications from specific genomic
loci. In mammals, H3 histone lysine 4 tri-
methylation (H3K4me3), a modification
localized at the transcription start site of
active genes (Li et al., 2007), is controlled
by enzymes of the SET and MLL (mixed
lineage leukemia) family. The family in-
cludes two SET and four MLL proteins
that can create three different complexes
with both unique and redundant features.
SET and MLL proteins have been associ-
ated with a wide variety of diseases—
ranging from cancer to mental disor-
ders—but their exact genetic functions
are largely unknown. To study the role of
MLL4 (the mouse ortholog is named
Wbp7) in the innate immune response,
Austenaa et al. (2012) generated Wbp7-
deficient macrophages. Using a com-
bined genomic approach, genome-wide
measurements of mRNA expression,
and chromatin state, they found that in
macrophages, Wbp7 is required for ro-
bust activation of pathogen-mediated
gene response. Surprisingly, whereas
Wbp7-depleted macrophages had a
severe defect in response to lipopolysa-
charide (LPS) challenge, the direct effect
of Wbp7, presented by genes whoseH3K4me3 levels were directly downregu-
lated by Wbp7 depletion, was restricted
to a small and very specific subset of
genes.
One direct target of Wbp7 is Pigp
(Figure 1), an essential component of the
glycosylphosphatidylinositol (GPI) anchor
synthesis pathway (Watanabe et al.,
2000). GPI anchor attachment is a critical
mechanism for localizing secreted sol-
uble proteins at the extracellular mem-
brane. Impaired Pigp expression in
Wbp7-depleted macrophages abolished
GPI anchor-dependent targeting of pro-
teins to the cell membrane. Detection of
many pathogens on the extracellular
surface is mitigated through a set of mole-
cules known as the Toll-like receptors
(TLR). LPS is effectively detected by
TLR4 only with its accessory coreceptor
CD14, which captures LPS and transfers
it to TLR4 (Akashi-Takamura and Miyake,
2008). CD14 is localized at the extracel-
lular membrane via a GPI anchor and is
mislocalized in Wbp7-depleted macro-
phages. As a consequence, the response
of Wbp7-depleted macrophages to LPS
and other bacterial molecules is greatly
attenuated (Figure 1). These findings
demonstrate how epigenetic changes
in one genomic locus can dramatically
shape gene expression at other loci and
promote a substantial physiological effect
in an indirect manner.
Memory in the immune system is
mostly attributed to the adaptive system,
through a dedicated mechanism of DNA-
dependent genome rearrangements. This
mechanism is critical for generating an
appropriate response to pathogens that
have been encountered in the history
of the organism. The study of Austenaa
et al. (2012) has the potential to lead to
an exciting new mechanism, allowing
innate immune cells to store memory
of past experience through activity ofImmunityspecific chromatin readers, writers, and
erasers that paint the epigenomic land-
scape and control its function in an ex-
perience-dependent manner. In macro-
phages reactivated by two consecutive
stimuli of LPS, a particular subset of the
stimulus-dependent induced genes is
not reactivated in the second pulse of
LPS. Genes that are not activated in the
second stimuli are mostly enriched for
various antibacterial proteins that are
toxic for the host in access quantities,
and therefore the hyporesponsiveness
is a mean of preventing severe tis-
sue damage. Interestingly, the memory
mechanism for the nonresponding genes
was suggested as addition of trimethyl
group on lysine 27 of the H3 histone
(H3K27me3), a repressive epigenomic
modification attenuating gene expression
(Foster et al., 2007). Because Wbp7
activity is crucial for CD14 proper mem-
brane localization and functionality and
because CD14 is an important rheostat
for TLR4 activity, a possible memory
mechanism of LPS hyporesponsiveness
could be Wbp7 inactivation after LPS
challenge. This will decrease CD14 ex-
pression and TLR4 responsiveness, a
hypothesis that requires further investiga-
tion in future studies.
There are 400 chromatin readers,
writers, and erasers in the human genome
that modify the epigenomic landscape
and control gene activation. The re-
sults presented here highlight a potential
role that individual chromatin modifiers
play in modulating the immune response.
Specifically, numerous chromatin modi-
fiers may participate in memory of past
pathogenic events in various tissues and
cells in the host, maintaining memory of
past experience though specific epi-
genomic modifications of various loci
responsible for appropriate immune re-
sponses. This mechanism was shown36, April 20, 2012 ª2012 Elsevier Inc. 551
Figure 1. Wbp7 Regulates Pigp Promoter H3K4me3 Modification and Transcriptional
Activation
Wbp7 modulates macrophage response to pathogens by regulating the expression of Pigp. Pigp, in turn,
regulates the GPI-anchor synthesis pathway, which directs CD14 to the extracellular membrane.
Membrane-tethered CD14 serves as an important accessory receptor for TLR4 and is critical for innate
immune response to pathogens.
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just as likely happen to coordinate
memory in the adaptive immune system,
increasing its arching complexity. In the
future, a systematic understanding of the
regulatory role of all chromatin modifiers
in the immune response (Amit et al.,
2011) would be of great significance for
effective therapeutics.
Chromatin readers, writers, and erasers
do not contain known sequence recogni-
tion motifs and it is mostly unknown how
they localize to specific genetic loci. A552 Immunity 36, April 20, 2012 ª2012 Elsevpotential mechanism is recruitment by
a combination of different transcription
factors (Young, 2011). Recent exciting
reports demonstrate a role for large non-
coding RNAs (lncRNA) in binding and
recruiting chromatin modifiers to site of
activity in a mechanism that is not fully
understood (Guttman et al., 2011; Wang
and Chang, 2011; Zhao et al., 2008).
These recent studies suggest that lncRNA
may be involved together with chromatin
complexes in regulating multiple physio-
logical response and malignancies. Inier Inc.this light it would be of great interest
to identify Wbp7-associated lncRNAs in
macrophages and to study their involve-
ment in localizing Wbp7 to Pigp and other
immune response genes.
The work of Austenaa et al. (2012)
demonstrates the power of a single chro-
matin-modifying enzyme in regulating an
important physiological process. With
no doubt, epigenetic research will con-
tinue providing fascinating findings on
the machinery of gene regulation in both
normal physiology and disease.
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